Paul Dent
Laurence Booth
Jane L. Roberts
Andrew Poklepovic2
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
- 1Departments of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, VA, United States
- 2Departments of Medicine, Virginia Commonwealth University, Richmond, VA, United States
- 3Department of Integrative Biology and Pharmacology, University of Texas Health Science Center, Houston, TX, United States
A Corrigendum on
Fingolimod Augments Monomethylfumarate Killing of GBM Cells
by Dent, P., Booth, L., Roberts, J. L., Poklepovic, A., and Hancock, J. F. (2020). Front. Oncol. 10:22. doi: 10.3389/fonc.2020.00022
In the original article, there was a mistake in Figure 7C as published. By error, the image for FAS-L treated with MMF was included twice; once correctly and once as FAS-L treated with vehicle control. The corrected Figure 7C for FAS-L assessments appears below.
FIGURE 7
Figure 7.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: fingolimod, dimethyl fumarate, Gilenya, Tecfidera, RAS, glioblastoma, microglia
Citation: Dent P, Booth L, Roberts JL, Poklepovic A and Hancock JF (2020) Corrigendum: Fingolimod Augments Monomethylfumarate Killing of GBM Cells. Front. Oncol. 10:684. doi: 10.3389/fonc.2020.00684
Received: 11 March 2020; Accepted: 14 April 2020;
Published: 30 April 2020.
Edited and reviewed by: Liam Chen, Johns Hopkins University, United States
Copyright © 2020 Dent, Booth, Roberts, Poklepovic and Hancock. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Paul Dent, cGF1bC5kZW50QHZjdWhlYWx0aC5vcmc=; Laurence Booth, bGF1cmVuY2UuYm9vdGhAdmN1aGVhbHRoLm9yZw==